(RTTNews) – Friday, Novo Nordisk A/S (NVO) announced that the Committee for Medicinal Products for Human Use under the European Medicines Agency has recommended marketing authorisation of Wegovy pill to reduce excess body weight and maintain long-term weight reduction.